The ISRS webinar program features presentations by global experts on a wide array of topics related to SRS/SBRT clinical practice, research and technological advancements. All webinars are archived and are available to members. Access the library here.
SRS in Multiple Metastatic Lesions
IRCCS Ospedale Sacro Cuore-Don Calabria, Negrar di Valpolicella, Verona, Italy
November 03, 2020, 1:00PM BST
Given systemic therapy advancements, patients live longer and approximately 20-40% of new cancer patients will develop brain metastases. No difference has been reported in overall survival between SRS/SRT alone compared to WBRT plus SRS. SRS alone achieved higher local control compared to WBRT. Results suggest that without WBRT in patients with five to ten brain metastases is non-inferior to that in patients with two to four brain metastases. Moreover, for patients with 2-10 BrM, SRS alone could be now considered as an appropriate treatment option for well-selected patients with good PS. Nevertheless, the reluctance of treating patients with more than 3-4 metastases with SRS remains and it is influenced by technical limitations of delivering SRS at an acceptable timing. New tools are allowing clinicians to approach these challenging situations. During the present webinar, the largest experiences on this topic will be discussed.
Stereotactic Radiosurgery for Pituitary Adenomas Following Surgery
Director of Functional Neurosurgery & Gamma Knife Unit
Humanitas Clinical and Research Center - IRCCS,
Rozzano (MI), Italy
November 12, 2020, 1:00PM BST
Stereotactic Radiosurgery (SRS) for Pituitary Adenomas is in the majority of cases an adjuvant treatment following Surgery. I will discuss the results in secreting and in non-secreting Pituitary Adenomas.
Spinal Meningioma Radiosurgery
Fondazione IRCCS Istituto Neurologico C Besta
Service unit of Radiotherapy, dept. of Neurosurgery
November 19, 2020, 1:00PM BST
Spinal meningioma are rare lesions. Despite this, considering the close intimate relationship with the spinal cord that characterizes such lesions, their treatment often represents a true challenge for all physicians. Radiosurgery represents a relatively new treatment paradigm for patients suffering from such tumors. Although preliminary reports are, at least, promising, radiosurgery for these benign spinal tumors tends to develop slowly, worldwide. Concern about potential radio-induced myelopathy is probably the most important limiting factor. The aim of this presentation is to explore the current literature about spinal meningioma radiosurgery and spinal cord tolerance and to present the results of our institutional experience.
Indications and Techniques for Radiosurgical Thalamotomy in the Modern Era
Professor of Neurosurgery, Radiation Oncology and Bioengineering
David Geffen School of Medicine at UCLA
Los Angeles, CA, USA
December 16, 2020, 1:00PM BST
Tremor is amongst the most prevalent neurological conditions and often refractory to medical therapy. While brain stimulation is an effective therapy, a resurgence of interest in ablation requires us to appreciate the success of radiosurgical thalamotomy, the technical and imaging advances that have advanced this treatment, and the opportunities to further enhance safety and efficacy.